Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2013

01.10.2013 | Retinal Disorders

Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up

verfasst von: Mihoko Suzuki, Fumi Gomi, Miki Sawa, Chikako Ueno, Kohji Nishida

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate changes in fundus autofluorescence (FAF) during 3 years of follow-up in patients with polypoidal choroidal vasculopathy (PCV).

Design

Retrospective study.

Methods

We retrospectively reviewed the charts of 48 eyes of 47 patients (35 men, 12 women; mean age, 69.9 ± 7.1 years) with treatment-naïve PCV for whom FAF and indocyanine green angiography (ICGA) images were available at baseline and at 3 years ± 3 months follow-up examination. The main outcome measures were the FAF changes during 3 years of follow-up, and the correlation between them and polypoidal lesions and branching vascular networks on ICGA.

Results

The FAF of the polypoidal lesions showed three patterns at baseline and changes during 3 years of follow-up: confluent hypoautofluorescence surrounded by a hyperautofluorescent ring (86.1 % → 51.4 %), confluent hypoautofluorescence without a ring (8.3 % → 43.0 %), and no marked changes (5.6 % → 5.6 %). The FAF in 96.2 % of resolved polypoidal lesions persisted on images with abnormal FAF during the 3 years of follow-up. The granular hypoautofluorescence at the branching vascular networks at baseline became partially confluent hypoautofluorescence in 41 eyes (85.4 %). The mean area with confluent hypoautofluorescence that corresponded to the branching vascular network lesions increased significantly (P < 0.001) from 1.75 mm2 to 5.10 mm2 after 3 years of follow-up.

Conclusion

The FAF changes in PCV during the 3 years of follow-up can indicate that FAF imaging is a useful and clinically beneficial tool for noninvasively evaluating the PCV lesions and disorders of the upper retinal pigment epithelium.
Literatur
1.
Zurück zum Zitat Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10(1):1–8PubMedCrossRef Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10(1):1–8PubMedCrossRef
2.
Zurück zum Zitat Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15(2):100–110PubMedCrossRef Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15(2):100–110PubMedCrossRef
3.
Zurück zum Zitat Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115(4):478–485PubMedCrossRef Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA (1997) The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 115(4):478–485PubMedCrossRef
4.
Zurück zum Zitat Yannuzzi LA, Nogueira FB, Spaide RF, Guyer DR, Orlock DA, Colombero D, Freund KB (1998) Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol 116(3):382–383PubMed Yannuzzi LA, Nogueira FB, Spaide RF, Guyer DR, Orlock DA, Colombero D, Freund KB (1998) Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol 116(3):382–383PubMed
5.
Zurück zum Zitat Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K (2012) Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy. Br J Ophthalmol 96(3):394–399PubMedCrossRef Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K (2012) Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy. Br J Ophthalmol 96(3):394–399PubMedCrossRef
6.
Zurück zum Zitat Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K, Ohtsuka H, Ariga H (2012) One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients. Am J Ophthalmol 154(1):117–124 e1PubMedCrossRef Hikichi T, Higuchi M, Matsushita T, Kosaka S, Matsushita R, Takami K, Ohtsuka H, Ariga H (2012) One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients. Am J Ophthalmol 154(1):117–124 e1PubMedCrossRef
7.
Zurück zum Zitat Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, Yoshimura N (2009) Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 29(1):52–59PubMedCrossRef Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, Yoshimura N (2009) Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 29(1):52–59PubMedCrossRef
8.
Zurück zum Zitat Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R (2007) Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 27(5):589–594PubMedCrossRef Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R (2007) Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 27(5):589–594PubMedCrossRef
9.
Zurück zum Zitat von Ruckmann A, Fitzke FW, Bird AC (1997) Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 38(2):478–486 von Ruckmann A, Fitzke FW, Bird AC (1997) Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 38(2):478–486
10.
Zurück zum Zitat von Ruckmann A, Fitzke FW, Bird AC (1997) In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 115(5):609–615CrossRef von Ruckmann A, Fitzke FW, Bird AC (1997) In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 115(5):609–615CrossRef
11.
Zurück zum Zitat Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3):718–729PubMed Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3):718–729PubMed
12.
Zurück zum Zitat Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42(5):1051–1056PubMed Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42(5):1051–1056PubMed
13.
Zurück zum Zitat Yamagishi T, Koizumi H, Yamazaki T, Kinoshita S (2012) Fundus autofluorescence in polypoidal choroidal vasculopathy. Ophthalmology 119(8):1650–1657PubMedCrossRef Yamagishi T, Koizumi H, Yamazaki T, Kinoshita S (2012) Fundus autofluorescence in polypoidal choroidal vasculopathy. Ophthalmology 119(8):1650–1657PubMedCrossRef
14.
Zurück zum Zitat Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U (2011) A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 118(9):1844–1851PubMedCrossRef Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U (2011) A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology 118(9):1844–1851PubMedCrossRef
15.
Zurück zum Zitat Otsuji T, Takahashi K, Fukushima I, Uyama M (2000) Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 31(3):210–214PubMed Otsuji T, Takahashi K, Fukushima I, Uyama M (2000) Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 31(3):210–214PubMed
16.
Zurück zum Zitat Iijima H, Iida T, Imai M, Gohdo T, Tsukahara S (2000) Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 129(1):21–26PubMedCrossRef Iijima H, Iida T, Imai M, Gohdo T, Tsukahara S (2000) Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 129(1):21–26PubMedCrossRef
17.
Zurück zum Zitat Ueno C, Gomi F, Sawa M, Nishida K (2012) Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 94(3):297–301 Ueno C, Gomi F, Sawa M, Nishida K (2012) Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy. Retina 94(3):297–301
18.
Zurück zum Zitat Akaza E, Yuzawa M, Mori R (2011) Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 55(1):39–44PubMedCrossRef Akaza E, Yuzawa M, Mori R (2011) Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 55(1):39–44PubMedCrossRef
19.
Zurück zum Zitat Kokame GT, Yeung L, Lai JC (2010) Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 94(3):297–301PubMedCrossRef Kokame GT, Yeung L, Lai JC (2010) Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results. Br J Ophthalmol 94(3):297–301PubMedCrossRef
20.
Zurück zum Zitat Saito M, Iida T, Kano M (2011) Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Retina 31(8):1589–1597PubMedCrossRef Saito M, Iida T, Kano M (2011) Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation. Retina 31(8):1589–1597PubMedCrossRef
Metadaten
Titel
Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up
verfasst von
Mihoko Suzuki
Fumi Gomi
Miki Sawa
Chikako Ueno
Kohji Nishida
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2336-1

Weitere Artikel der Ausgabe 10/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.